# INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions

> **NCT05653024** · PHASE3 · TERMINATED · sponsor: **Philippe Bégin** · enrollment: 24 (actual)

## Conditions studied

- IgE-mediated Abdominal Pain

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05653024
- **Lead sponsor:** Philippe Bégin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-01
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Study was stopped due to unforseen changes in clinical practice (new oral immunotherapy focus on infants and toddlers) which led to a decrease in eligible participants and failure to meet recruitement targets.
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05653024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05653024, "INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05653024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*